BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Hypothalamus
,
Autoimmunity
,
Lovastatin
,
rs6983267
,
PBX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
regulation of protein kinase C signaling
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Vena cava
Uterus
Tongue superior part with papillae
Bladder
Skeletal muscle psoas
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Alpha-1-antitrypsin deficiency
Disorder of digestive system
Pyloric ulcer
Vesicular stomatitis Indiana virus disease
Legionella infection
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
CGP 60474
Glesatinib
A 443654
OTS-167
AT 7519
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
ANKRD2
DIDO1
POLH
FGF13
TLK2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Tumor-associated macrophages from mice receiving breast tumor 4T1 cell allograft
Tumor formation by ATG5 KO cells
L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7.311 cells with CRISPR-induced gene knockouts
L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for regulation of protein kinase C signaling
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepa…
Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With…
Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone I…
The Possible Neuroprotective Effect of Ocrelizumab Via VEGF Protein Expression in Relapsing Multiple…
Immune Modulation by Ischemic Pre-conditioning in Healthy Individuals: Intracellular Signalling in R…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ